Literature DB >> 23798315

Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.

Hiromitsu Hayashi1, Toru Beppu, Toshiro Masuda, Hirohisa Okabe, Katsunori Imai, Daisuke Hashimoto, Yoshiaki Ikuta, Akira Chikamoto, Masayuki Watanabe, Hideo Baba.   

Abstract

BACKGROUND: Partial splenic embolization (PSE) for cirrhotic patients has been reported not only to achieve an improvement in thrombocytopenia and portal hypertension, but also to induce PSE-associated fringe benefit such as individual liver functional improvement. The purpose of this study was to clarify the predictive marker of liver functional improvement due from PSE in cirrhotic patients.
METHODS: From April 1999 to January 2009, 83 cirrhotic patients with hypersplenism-induced thrombocytopenia (platelet count <10 × 10(4)/μl) underwent PSE. Of them, 71 patients with follow-up for more than one year after PSE were retrospectively investigated.
RESULTS: In liver tissues after PSE, proliferating cell nuclear antigen (PCNA)-positive hepatocytes were remarkably increased, speculating that PSE induced liver regenerative response. Indeed, serum albumin and cholinesterase levels increased to 104 ± 14% and 130 ± 65% each of the pretreatment level at one year after PSE. In a multiple linear regression analysis, preoperative splenic volume was extracted as the predictive factor for the improvement in cholinesterase level after PSE. Cirrhotic patients with preoperative splenic volume >600 ml obtained significantly higher serum albumin and cholinesterase levels at one year after PSE compared to those with less than 600 ml (P-values were 0.029 in both).
CONCLUSION: A large preoperative splenic volume was the useful predictive marker for an effective PSE-induced liver functional improvement.
© 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Liver cirrhosis; Liver functional improvement; Partial splenic embolization; Preoperative splenic volume

Mesh:

Substances:

Year:  2013        PMID: 23798315     DOI: 10.1002/jhbp.1

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  4 in total

1.  Pediatric liver cirrhosis interventional procedures: from biopsy to transjugular intrahepatic portosystemic shunt.

Authors:  Gian Luigi Natali; Giulia Cassanelli; Guglielmo Paolantonio; George Koshy Parapatt; Lorenzo Maria Gregori; Massimo Rollo
Journal:  Pediatr Radiol       Date:  2022-09-19

Review 2.  Partial splenic artery embolization in cirrhotic patients.

Authors:  Tyson A Hadduck; Justin P McWilliams
Journal:  World J Radiol       Date:  2014-05-28

3.  Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial.

Authors:  Yanjing Gao; Xin Sun; Anzhong Zhang; Tao Zhou; Minghui Wang; Yong Chen; Ting Zhou; Xiaoning Chen; Aiyuan Xiu; Zhi Peng; Baoquan Cheng; Xiaofeng Liu
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

4.  Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification.

Authors:  Tsuyoshi Ishikawa; Ryo Sasaki; Tatsuro Nishimura; Takashi Matsuda; Takuya Iwamoto; Issei Saeki; Isao Hidaka; Taro Takami; Isao Sakaida
Journal:  Intern Med       Date:  2020-12-07       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.